Archive #6817

Metadata

Bill Number: SB26-031
HTTP Status: 200
Valid JSON: Valid
Archived At: 2026-02-18 15:05:05 MST
Created At: 2026-02-18 15:05:05 MST

Parsed JSON

{
  "votes": [],
  "active": "T",
  "origin": "Senate",
  "lls_num": "26-0114",
  "session": "2026A",
  "subject": [
    "Crimes, Corrections, & Enforcement"
  ],
  "bill_num": "SB26-031",
  "sponsors": [
    {
      "id": "SC001",
      "title": "Representative",
      "s_type": "Prime Sponsor",
      "chamber": "House",
      "full_name": "Sean Camacho",
      "last_name": "Camacho",
      "first_name": "Sean",
      "sponsor_order": "3"
    },
    {
      "id": "MS003",
      "title": "Representative",
      "s_type": "Prime Sponsor",
      "chamber": "House",
      "full_name": "Matt Soper",
      "last_name": "Soper",
      "first_name": "Matt",
      "sponsor_order": "4"
    },
    {
      "id": "WL001",
      "title": "Senator",
      "s_type": "Prime Sponsor",
      "chamber": "Senate",
      "full_name": "William Lindstedt",
      "last_name": "Lindstedt",
      "first_name": "William",
      "sponsor_order": "1"
    },
    {
      "id": "JR002",
      "title": "Senator",
      "s_type": "Prime Sponsor",
      "chamber": "Senate",
      "full_name": "Janice Rich",
      "last_name": "Rich",
      "first_name": "Janice",
      "sponsor_order": "2"
    }
  ],
  "bill_files": [
    {
      "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_01.pdf",
      "date": "01/22/2026",
      "label": "Introduced",
      "url_html": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_01.html",
      "lastModified": "01/22/2026 11:50:18 AM"
    }
  ],
  "committees": [
    {
      "id": "S_HHS_2026A",
      "name": "Health & Human Services",
      "chamber": "Senate"
    }
  ],
  "long_title": "Concerning the lawful use of a prescription drug product containing a schedule I controlled substance.",
  "bill_status": "Senate Second Reading",
  "short_title": "Use of Prescription Prod with Controlled Substance",
  "bill_summary": "<html><body><p><t></t></p><p>The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is:</p><p><ul><li>Approved for prescription use by the United States food and drug administration; and<li>Designated or rescheduled by the United States drug enforcement agency (DEA).</li></ul><t></t></p><p>The exemption applies upon the DEA's designation or rescheduling.</p><p><t></t></p><p>The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>",
  "progress_bar": [
    {
      "end": "F",
      "label": "Introduced",
      "position": 1
    },
    {
      "end": "F",
      "label": "Under Consideration",
      "position": 2
    }
  ],
  "special_type": "",
  "bill_category": "Criminal Law & Procedure",
  "allow_testimony": "F",
  "amendment_files": [
    {
      "url": "https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/9FA8AE07653993B487258D9C0068476E/SB031_L.001.pdf",
      "date": "02/12/2026 01:36:02 PM",
      "vote": "Passed*",
      "chamber": "Senate",
      "hearing": "SEN Health & Human Services",
      "url_html": "https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/9FA8AE07653993B487258D9C0068476E/SB031_L_001.html",
      "amendment": "L.001"
    }
  ],
  "full_bill_topic": "Use of Prescription Product with Controlled Substance",
  "long_bill_files": [],
  "GHG_report_files": [],
  "preamended_files": [
    {
      "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_S_HHS_01.pdf",
      "date": "02/13/2026",
      "label": "PA1",
      "url_html": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_S_HHS_01.html",
      "lastModified": "02/17/2026 09:25:25 AM",
      "label_detailed": "Senate Health & Human Services Preamend"
    }
  ],
  "bill_sub_category": "Controlled Substances and Drugs",
  "fiscal_note_files": [
    {
      "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_00.pdf",
      "date": "02/02/2026",
      "label": "FN1",
      "url_html": "",
      "lastModified": "02/11/2026 01:48:57 PM",
      "label_detailed": "Initial Fiscal Note"
    }
  ],
  "is_budget_package": "No",
  "session_laws_files": "",
  "summarized_history": [
    {
      "date": "02/18/2026",
      "action": "Senate Second Reading Laid Over to 02/23/2026 - No Amendments",
      "location": "Senate"
    },
    {
      "date": "02/12/2026",
      "action": "Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole",
      "location": "Senate"
    },
    {
      "date": "02/04/2026",
      "action": "Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only",
      "location": "Senate"
    },
    {
      "date": "01/22/2026",
      "action": "Introduced In Senate - Assigned to Health & Human Services",
      "location": "Senate"
    }
  ],
  "research_note_files": [],
  "bill_sub_sub_category": "Schedule of Controlled Substances",
  "committee_report_files": [
    {
      "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_S_HHS_001.pdf",
      "date": "02/12/2026",
      "label": "S_HHS_2026A",
      "url_html": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_S_HHS_001.html",
      "lastModified": "02/13/2026 09:50:34 AM"
    }
  ],
  "demographic_note_files": [],
  "updated_bill_summary_files": [],
  "budget_staff_analysis_files": [],
  "first_chamber_third_reading_date": "",
  "second_chamber_third_reading_date": ""
}

Raw Response

{"bill_num":"SB26-031","lls_num":"26-0114","origin":"Senate","short_title":"Use of Prescription Prod with Controlled Substance","full_bill_topic":"Use of Prescription Product with Controlled Substance","long_title":"Concerning the lawful use of a prescription drug product containing a schedule I controlled substance.","special_type":"","bill_category":"Criminal Law & Procedure","bill_sub_category":"Controlled Substances and Drugs","bill_sub_sub_category":"Schedule of Controlled Substances","is_budget_package":"No","subject":["Crimes, Corrections, & Enforcement"],"bill_status":"Senate Second Reading","sponsors":[{"id":"SC001","title":"Representative","first_name":"Sean","last_name":"Camacho","full_name":"Sean Camacho","s_type":"Prime Sponsor","chamber":"House","sponsor_order":"3"},{"id":"MS003","title":"Representative","first_name":"Matt","last_name":"Soper","full_name":"Matt Soper","s_type":"Prime Sponsor","chamber":"House","sponsor_order":"4"},{"id":"WL001","title":"Senator","first_name":"William","last_name":"Lindstedt","full_name":"William Lindstedt","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"1"},{"id":"JR002","title":"Senator","first_name":"Janice","last_name":"Rich","full_name":"Janice Rich","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"2"}],"committees":[{"id":"S_HHS_2026A","chamber":"Senate","name":"Health & Human Services"}],"first_chamber_third_reading_date":"","second_chamber_third_reading_date":"","summarized_history":[{"date":"02/18/2026","location":"Senate","action":"Senate Second Reading Laid Over to 02/23/2026 - No Amendments"},{"date":"02/12/2026","location":"Senate","action":"Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole"},{"date":"02/04/2026","location":"Senate","action":"Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only"},{"date":"01/22/2026","location":"Senate","action":"Introduced In Senate - Assigned to Health & Human Services"}],"progress_bar":[{"position":1,"label":"Introduced","end":"F"},{"position":2,"label":"Under Consideration","end":"F"}],"active":"T","session":"2026A","allow_testimony":"F","long_bill_files":[],"bill_files":[{"date":"01/22/2026","lastModified":"01/22/2026 11:50:18 AM","label":"Introduced","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_01.pdf","url_html":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_01.html"}],"fiscal_note_files":[{"date":"02/02/2026","lastModified":"02/11/2026 01:48:57 PM","label":"FN1","label_detailed":"Initial Fiscal Note","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_00.pdf","url_html":""}],"research_note_files":[],"budget_staff_analysis_files":[], "preamended_files":[{"date":"02/13/2026","lastModified":"02/17/2026 09:25:25 AM","label":"PA1","label_detailed":"Senate Health & Human Services Preamend","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_S_HHS_01.pdf","url_html":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/031_S_HHS_01.html"}],"committee_report_files":[{"date":"02/12/2026","lastModified":"02/13/2026 09:50:34 AM","label":"S_HHS_2026A","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_S_HHS_001.pdf","url_html":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/7C602D6BCB4B764887258D04005ED91D/$File/SB031_S_HHS_001.html"}],"updated_bill_summary_files":[],"demographic_note_files":[],"GHG_report_files":[],"bill_summary":"<html><body><p><t></t></p><p>The bill exempts from schedule I a prescription drug product containing the schedule I controlled substance (product) if the product is:</p><p><ul><li>Approved for prescription use by the United States food and drug administration; and<li>Designated or rescheduled by the United States drug enforcement agency (DEA).</li></ul><t></t></p><p>The exemption applies upon the DEA's designation or rescheduling.</p><p><t></t></p><p>The bill requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA.</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>","amendment_files":[{"chamber":"Senate","date":"02/12/2026 01:36:02 PM","amendment":"L.001","hearing":"SEN Health & Human Services","vote":"Passed*","url":"https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/9FA8AE07653993B487258D9C0068476E/SB031_L.001.pdf","url_html":"https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/9FA8AE07653993B487258D9C0068476E/SB031_L_001.html"}],"session_laws_files":"","votes":[]}